Numerous investigations have assessed the therapeutic effectiveness of PD-1 inhibitors when combined with chemotherapy for advanced biliary tract cancer (9–11).The combination of PD-1 inhibitors with chemotherapy significantly improved the median OS in patients with advanced ICC compared to PD-1 inhibitors alone and chemotherapy alone (10). This evidence concerns the gene PDCD1 and biliary tract neoplasm.